Page last updated: 2024-08-23

mifepristone and Addison Disease

mifepristone has been researched along with Addison Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arvat, E; Boscaro, M; Broglio, F; Deghenghi, R; Ghigo, E; Giordano, R; Maccagno, B; Ramunni, J	1
Ellerkamp, V; Hoffmann, MW; Klebs, SH; Klempnauer, J; Musholt, PB; Musholt, TJ; Scheumann, GF	1
Barnes, K; Chrousos, GP; Laue, L; Loriaux, DL; Munson, P; Nieman, L; Schaison, G	1

Trials

2 trial(s) available for mifepristone and Addison Disease

Article	Year
Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease. Neuroendocrinology, 1999, Volume: 70, Issue:3 Topics: Addison Disease; Adrenocorticotropic Hormone; Adult; Aged; Female; Growth Substances; Hormone Antagonists; Human Growth Hormone; Humans; Hydrocortisone; Male; Metyrapone; Middle Aged; Mifepristone; Oligopeptides; Receptors, Glucocorticoid	1999
The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man. The Journal of clinical endocrinology and metabolism, 1988, Volume: 66, Issue:2 Topics: Addison Disease; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Animals; Corticotropin-Releasing Hormone; Cushing Syndrome; Estrenes; Female; Glucocorticoids; Humans; Hydrocortisone; Male; Middle Aged; Mifepristone; Progestins	1988

Article

Year

Corticotropin-releasing effect of hexarelin, a peptidyl GH secretagogue, in normal subjects pretreated with metyrapone or RU-486, a glucocorticoid receptor antagonist, and in patients with Addison's disease.

Neuroendocrinology, 1999, Volume: 70, Issue:3

Topics: Addison Disease; Adrenocorticotropic Hormone; Adult; Aged; Female; Growth Substances; Hormone Antagonists; Human Growth Hormone; Humans; Hydrocortisone; Male; Metyrapone; Middle Aged; Mifepristone; Oligopeptides; Receptors, Glucocorticoid

1999

The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.

The Journal of clinical endocrinology and metabolism, 1988, Volume: 66, Issue:2

Topics: Addison Disease; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Animals; Corticotropin-Releasing Hormone; Cushing Syndrome; Estrenes; Female; Glucocorticoids; Humans; Hydrocortisone; Male; Middle Aged; Mifepristone; Progestins

1988

Other Studies

1 other study(ies) available for mifepristone and Addison Disease

Article	Year
A murine model of allogeneic adrenocortical cell transplantation: perspectives for the treatment of Addison's disease in humans. Surgery, 2000, Volume: 128, Issue:6 Topics: Addison Disease; Adrenal Cortex; Adrenal Cortex Hormones; Animals; Cell Transplantation; Cells, Cultured; Coculture Techniques; Histocompatibility Antigens Class I; Humans; Lymphocyte Culture Test, Mixed; Mice; Mice, Transgenic; Mifepristone; T-Lymphocytes; Transplantation, Homologous	2000

Article

Year

A murine model of allogeneic adrenocortical cell transplantation: perspectives for the treatment of Addison's disease in humans.

Surgery, 2000, Volume: 128, Issue:6

Topics: Addison Disease; Adrenal Cortex; Adrenal Cortex Hormones; Animals; Cell Transplantation; Cells, Cultured; Coculture Techniques; Histocompatibility Antigens Class I; Humans; Lymphocyte Culture Test, Mixed; Mice; Mice, Transgenic; Mifepristone; T-Lymphocytes; Transplantation, Homologous

2000